Abstract
Get full access to this article
View all access options for this article.
References
1.
Chan
IS
,
Ginsburg
GS
2011 . Personalized medicine: progress and promise . Annu Rev Genomics Hum Genet , 12 :217 -244 .
2.Cogent Research Attitudes & Trends (CGAT) Study . 2010 . www.genomeweb.com/dxpgx/survey-shows-declining-public-interest-pgx-poor-grasp-genomics-issues. 2011 December 29 .
3.
Feero
WG
,
Guttmacher
AE
,
Collins
FS
2008 . The genome gets personal—almost . JAMA , 299 :1351 -1352 .
4.
Grosse
SD
,
Kalman
L
,
Khoury
MJ
2010 . Evaluation of the validity and utility of genetic testing for rare diseases . Adv Exp Med Biol , 686 :115 -131 .
5.
Guttmacher
AE
,
Collins
FS
2003 . Welcome to the genomic era . N Engl J Med , 349 :996 -998 .
6.
Horn
EJ
,
Edwards
K
,
Terry
SF
2011 . Engaging research participants and building trust . Genet Test Mol Biomarkers , 15 :839 -840 .
7.Institute of Medicine . 2011 . Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary . www.iom.edu/Reports/2011/Generating-Evidence-for-Genomic-Diagnostic-Test-Development.aspx. 2011 December 29 .
8.Personalized Medicine Coalition . 2011 . The case for personalized medicine . www.personalizedmedicinecoalition.org/sites/default/files/files/Case_for_PM_3rd_edition.pdf. 2011 December 19 .
9.
Terry
SF
,
Terry
PF
2011 . Power to the people: participant ownership of clinical trial data . Sci Transl Med , 3 :69cm3 .